1-3 of 3
Metban Mastanzade
Close
Sort by
Journal Articles

An Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of Therapy

Omur Gokmen Sevindik, Zubeyde Nur Ozkurt, Can Boga, Sevgi Kalayoglu Besisik, Yildiz Ipek, Ayfer Geduk, Aybuke Harmandali, Ayse Salihoglu, Handan haydaroglu Sahin, Mehmet Sönmez, Filiz Vural, Olga Meltem Akay, Meltem Kurt Yuksel, Senem Maral, Omer Ekinci, Onur Hakki Kirkizlar, Atakan Tekinalp, Nazli Demir, Mustafa Merter, Guray Saydam, İnci Alacacıoğlu, Zeynep Arzu Yegin, Mutlu Kasar, Metban Mastanzade, Guner Hayri Ozsan
Journal: Blood
Blood (2021) 138 (Supplement 1): 4730.
https://doi.org/10.1182/blood-2021-150175
Published: 2021
Journal Articles

R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux ®) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience

Murat Ozbalak, Metban Mastanzade, Ozden Ozluk, Tarik Onur Tiryaki, Simge Erdem, Ezgi Pınar Özbalak, Tuğrul Elverdi, Ipek Yonal Hindilerden, Mustafa Nuri Yenerel, Teoman Soysal, Meliha Nalcaci, Burhan Ferhanoglu, Sevgi Kalayoglu Besisik
Journal: Blood
Blood (2021) 138 (Supplement 1): 4585.
https://doi.org/10.1182/blood-2021-145810
Published: 2021
Journal Articles

The Importance of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: A Cohort Study

Mustafa Nuri Yenerel, MD, Simge Erdem, MD, Metban Mastanzade, Meliha Nalcaci
Journal: Blood
Blood (2018) 132 (Supplement 1): 4876.
https://doi.org/10.1182/blood-2018-99-119480
Published: 2018